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Introduction
Clostridium difficile is an important nosocomial pathogen globally. In North America, investigators have drawn attention to increasing rates of C. difficile infection (CDI) among those without traditional risk factors such as exposure to healthcare facilities or extensive broad-spectrum antibiotics [1] . These community-associated (CA) cases are often not identified by conventional surveillance and infection control activities. In
North America, they have been linked to the 027 ribotype [2] , which has also been described in a small cluster in Singapore [3] . To better define the epidemiology of CA-CDI [4] , a prospective, hospital-based, cross-sectional study of CDI cases was undertaken to describe the prevalence, risk factors, clinical features and ribotypes of CDI at a tertiary care hospital in Singapore.
Methods

Site
The study was conducted in National University Hospital (NUH), a 1000-bed tertiary care hospital in Singapore, with active haematology, oncology, neurosurgery, cardiothoracic surgery and transplant services covering both children and adults.
Over the study period, NUH recorded 152 377 patient-days and 25 544 discharges, or a caseload of 304 754 patient-days/year and 51 088 discharges/year.
Case finding
All laboratory-confirmed CDI cases who were 21 years old at time of hospitalisation and who gave informed consent were included in the study over the 6-month period Assessment of cause of death and clinical evidence of severity was performed by a single experienced infectious diseases physician based on pre-defined criteria.
Other data
Denominator data such as total number of stool samples sent to the laboratory and number of patients at risk were derived from the computerised laboratory and hospital databases, respectively.
Definitions
Cases of CDI were defined as inpatients with three or more unformed or loose stools conforming to the shape of a container (diarrhoea) within a 24-h period and positive for C. difficile toxin A or B, or glutamate dehydrogenase (GDH)-positive and PCRpositive for toxin-negative cases. Cases were classified by healthcare facility exposure according to the Society for Healthcare Epidemiology of America (SHEA)
guidelines [5] . Healthcare-facility associated (HCFA) cases included hospital-onset (HCFA-HO) cases whose symptom onset was in hospital and >48 h after admission, and community-onset (HCFA-CO) cases whose symptoms began within 4 weeks of discharge from hospital. Community-associated (CA) cases were those who had not been discharged from any hospital in the preceding 12 weeks with symptom onset The SHEA definitions of severe and severe complicated CDI were used and thus severe CDI was defined when a patient had one or more of the following:
leukocytosis with a white blood cell count of 15 000 cells/ L; a serum creatinine level 1.5 times than the pre-morbid level (or if pre-morbid level unknown, 1.5 times above the normal range) [5] . Severe complicated cases were those with hypotension or shock, ileus or megacolon contributed by CDI.
Statistical methods
Analysis was conducted using SPSS software v.20 (IBM Corp., Armonk, NY).
Statistical tests were two-sided, and P-values of <0.05 were considered to indicate statistical significance.
Laboratory methods
Testing of stool for C. difficile was performed according to the standard laboratory procedure in NUH using the C DIFF QUIK CHEK COMPLETE ® test (TECHLAB ® Inc., Blacksburg, VA), a combination lateral flow assay that tests for GDH as well as toxins A and B. All toxin-positive or GDH-positive samples on the lateral flow assay were subjected to PCR using the Xpert ® C. difficile test (Cepheid, Sunnyvale, CA) and were ribotyped by PCR [6] . Toxin-positive cases and those that were both GDHpositive and PCR-positive were included. Crude bacterial template DNA for toxin profiling was prepared by re-suspension of cells in a 5% (w/v) solution of Chelex-100
A c c e p t e d M a n u s c r i p t 7 resin (Sigma-Aldrich, Castle Hill, NSW, Australia). PCR ribotyping was performed as previously described by Stubbs et al. [7] . PCR ribotyping reaction products were Isolates that could not be identified with the available reference library were designated with internal nomenclature.
Ethical approval
Participants or their legally authorised representatives gave informed consent to be included in the study. Ethical approval for the study was granted by the Domain Specific Review Board of Singapore's National Healthcare Group.
Results
During the study period, 1642 stool samples were sent for C. difficile testing. In total, 158 instances of CDI were identified in stool specimens submitted to the clinical laboratory. Of the 158 cases of CDI identified, 69 were unable to be assessed for eligibility owing to discharge prior to identification by study co-ordinators, death or a A c c e p t e d M a n u s c r i p t 8 language barrier. Of the 89 cases assessed for eligibility, 13 cases were ineligible as they did not meet the minimum age requirement, 4 cases were ineligible as they had not passed three stools in the 24 h prior to C. difficile testing and 3 cases were ineligible as they were recurrent cases. Of the eligible patients, only three declined to participate in the study, giving a response rate of 95.7%. Thus, 66 cases were recruited for the study (Fig. 1) .
Incidence
The incidence of laboratory-confirmed CDI in this hospital was 10.7/10 000 patientdays or 6.38/1000 discharges. The median length of stay (LoS) for patients with CDI was 23.5 days; comparatively, the overall median LoS is 6.1 days for all patients in NUH.
Demographics and risk factors
The mean age of studied patients was 62.3 years, and 36 (54.5%) were male ( 
Hospital-onset versus community-onset Clostridium difficile infection
Using the SHEA definitions, 33 cases (50.0%) were HCFA-HO and 33 cases (50.0%) were CO. Of the 33 CO cases, 14 (42.4%) were HCFA-CO, 10 (30.3%)
were indeterminate and 9 (27.3%) were CA. Of the CA cases, a majority (88.9%)
had prior exposure to a healthcare facility within the last 12 weeks (within the past 12 weeks, six had visited a specialist outpatient clinic, two had visited a primary care clinic and only one had not visited any healthcare facility). Table 2 compares clinical features, exposures and outcomes for CO and HO cases.
There was no significant difference in the mean age or sex according to site of onset.
Of the nine CA cases, eight (88.9%) reported no recent exposure to antibiotics. The median time from onset of diarrhoeal symptoms to the diagnostic specimen being sent was significantly longer for CO cases than for HO cases (4 days vs. 1 day; P = 0.014). HO cases had a significantly longer median LoS from the onset of diarrhoea (14 days vs. 22 days; P < 0.01).
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Ribotypes
Ribotypes were available for 61 isolates (92.4%). Of these, 42 corresponded to known ribotypes, the predominant strains being 053 and 012 (Table 3) . Ribotype 053
was the most frequent both in CO and HO cases (17.9% and 24.2%, respectively).
The prevalence of different ribotypes did not differ between CO-CDI and HO-CDI cases.
Discussion
Clostridium difficile has been recognised as an emerging pathogen especially in Europe and North America. This study supports the high incidence of CDI in
Singapore. The rate of 10.7/10 000 patient-days or 6.38/1000 discharges is consistent with the increasing prevalence observed by others [8] . Whereas Lim et al. Concurrently, use of broad-spectrum antibiotics has increased [12] . Given the attributable cost per episode of CDI of US$2470-3669 [13] , CDI is clearly a disease with great impact in Southeast Asia and there is an urgent need for improved control in the hospital and beyond.
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A high proportion of CA-CDI amongst the CO-CDI was observed in this study, markedly different from previous studies in Singapore [14] and elsewhere in Asia [15] , but similar to reports from Sweden (22-28%) [16, 17 [ and the USA (18-20%) [2] .
In contrast to Dumyati et al. [2] , most CA cases in the current study did not recall prior exposure to antibiotics, but all except one had actually been treated in an McDonald surveillance definition [19] . However, it is not clear that there was any real difference in clinical features between HO and CO cases in any case.
A substantial proportion of the isolates were of novel ribotypes that have not been previously defined (31.1%), demonstrating the diversity of strains in Singapore. This diversity may be attributable to the high use of imported food from widespread areas to Singapore.
The majority of patients with CDI have 053 or 012 strains; it is not surprising that the most prevalent ribotypes in HO-CDI and CO-CDI patients were similar given the movement of patients between hospitals and the community. Moreover, most patients had reported recent contact with a healthcare facility.
In previous reports, the 027 ribotype was implicated in a limited number of CO-CDI in Singapore [3] and the USA [2] . It is possible that we might have missed sporadic cases of 027 CDI but there were no sustained outbreaks to our knowledge during the study period. The ribotypes most prevalent in Singapore are different from those reported in other studies in Asia [20] [21] [22] , North America and Europe [20, 23] . In studies in Europe, ribotypes 078, 014 and 172 were most commonly found in CO-CDI cases in The Netherlands [24] , whilst ribotypes 001 and 027 were most common in the UK [25] .
A limitation of this study was the number of patients not successfully recruited before discharge and not invited to participate in the study. It is possible that the patients not invited had a shorter LoS than those recruited because they were less ill.
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However, there is no reason to suspect that this would lead to over-representation of CO-CDI.
Conclusion
CO A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t 24   Table 3 Ribotypes by community-onset (CO) and hospital-onset ( Edited Figure 1 
